Medical and Pharmaceutical Research shines light on efficacy of ‘Inflammacheck’ lung cancer breath test Small study yielded high accuracy, though larger-scale validation is still needed Rowan Dunne2 days ago
Medical and Pharmaceutical New USD$60 blood test detects lung cancer using DNA chemical fingerprints The team extracts cell-free DNA from a blood sample and chemically processes selected sections Joseph Morton3 days ago
Medical and Pharmaceutical Manitoba Lung Association and BioMark use blood biopsy to tackle radon threat They are organising a feasibility study assessing the efficacy of BioMark's blood test on those exposed to the gas Rowan DunneAugust 9, 2026
Medical and Pharmaceutical Lung cancer screening awareness remains low despite advances in early detection The 2026 Lung Health Barometer found only 33 per cent of adults knew low-dose CT screening is available for high-risk people Joseph MortonAugust 6, 2026
Medical and Pharmaceutical Median Technologies partners with Canon Medical to achieve lung cancer screening goals Their collaboration seeks to expedite deployment of Median's AI-powered nodule detection system Rowan DunneJuly 31, 2026
AI and Autonomy Four tech startups turning to Regulation Crowdfunding: A Mugglehead roundup The system makes it easier for smaller companies to access capital while preserving investor protections Joseph MortonJuly 23, 2026
Medical and Pharmaceutical Cizzle Biotech rises 16% from U.S. launch of lung cancer blood test The CIZ1B test is meant to complement LDCT in detecting early-stage disease Rowan DunneJuly 23, 2026
Medical and Pharmaceutical Cancer detection specialist Freenome lists on Nasdaq through special purpose merger Freenome has been developing its blood biopsy platform for more than a decade Rowan DunneJuly 20, 2026
Medical and Pharmaceutical AI-powered light scan could speed up targeted lung cancer treatments This technique, fluorescence lifetime imaging microscopy, could save patients and hospitals alot of money Rowan DunneJuly 13, 2026
Medical and Pharmaceutical MIT continues advancing ‘PlasmoSniff’ pneumonia breath test The prestigious school is one of a select few active with breath sampling tech for this infection Rowan DunneJune 25, 2026